Meeting Overview - The company is holding a temporary shareholders' meeting to discuss various proposals, including the 2025 restricted stock incentive plan [1][2] - The meeting will follow specific procedures to ensure order and efficiency, with provisions for shareholder participation and questioning [1][2] Agenda Items - Proposal 1: Discussion on the company's 2025 interim dividend plan, which aims to enhance shareholder returns [2][3] - Proposal 2: Review of the 2025 restricted stock incentive plan draft and its summary [2][6] - Proposal 3: Examination of the implementation assessment management measures for the 2025 restricted stock incentive plan [2][7] - Proposal 4: Authorization for the board to handle matters related to the 2025 restricted stock incentive plan [2][9] - Proposal 5: Cancellation of the supervisory board and amendments to the company's business scope and articles of association [2][11] - Proposal 6: Development and revision of certain governance systems [2][12] - Proposal 7: Review of candidates for the second board's independent directors and their annual allowances [2][13] Dividend Proposal - The company proposes a mid-year dividend not exceeding 30% of the net profit attributable to shareholders for 2025 [3][4] - The proposed cash dividend is 1.6 yuan per 10 shares, totaling approximately 65.82 million yuan, which represents 29.89% of the net profit for the first half of 2025 [5][6] Restricted Stock Incentive Plan - The company aims to implement a restricted stock incentive plan to attract and retain talent, aligning the interests of shareholders, the company, and core team members [6][7] - The plan's details will be disclosed on August 28, 2025, and it has been approved by the board and supervisory committee [7][9] Governance Changes - The company plans to abolish the supervisory board and amend its articles of association to comply with updated regulations [11] - Several governance systems will be revised to enhance operational standards and compliance with regulatory requirements [12] Independent Director Nomination - The company proposes to nominate Zhang Zhenhua as an independent director, with an annual allowance of 150,000 yuan [13][14] - Zhang Zhenhua meets all qualifications and independence criteria as per relevant regulations [14][15]
威高血净: 山东威高血液净化制品股份有限公司2025年第一次临时股东大会会议资料